The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Intravenous Vitamin C and Cancer: A Systematic Review
Open accessAbstract
Background. Intravenous vitamin C (IVC) is a contentious adjunctive cancer therapy, widely used in naturopathic and integrative oncology settings. We conducted a systematic review of human interventional and observational studies assessing IVC for use in cancer patients. Methods. We searched MEDLINE, EMBASE, The Cochrane Library, CINAHL, and AMED from inception to April 2013 for human studies examining the safety, effectiveness, or pharmacokinetics of IVC use in cancer patients. Results. Of 897 records, a total of 39 reports of 37 studies were included: 2 randomized controlled trials (RCTs), 15 uncontrolled trials, 6 observational studies, and 14 case reports. IVC dosing ranged from 1 g to more than 200 g ascorbic acid per infusion, typically administered 2 to 3 times weekly. IVC does not appear to increase toxicity or interfere with antitumor effects of gemcitabine/erlotinib therapy or paclitaxel and carboplatin. Based on 1 RCT and data from uncontrolled human trials, IVC may improve time to relapse and possibly enhance reductions in tumor mass and improve survival in combination with chemotherapy. IVC may improve quality of life, physical function, and toxicities associated with chemotherapy, including fatigue, nausea, insomnia, constipation, and depression. Case reports document several instances of tumor regression and long-term disease-free survival associated with use of IVC. Conclusion. There is limited high-quality clinical evidence on the safety and effectiveness of IVC. The existing evidence is preliminary and cannot be considered conclusive but is suggestive of a good safety profile and potentially important antitumor activity; however, more rigorous evidence is needed to conclusively demonstrate these effects. IVC may improve the quality of life and symptom severity of patients with cancer, and several cases of cancer remission have been reported. Well-designed, controlled studies of IVC therapy are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A significant number of clinical trials have indicated that vitamin C administered intravenously in high-doses (in most trials, 50–100 g twice or thrice weekly) as a treatment for various cancers including glioblastoma, ovarian, prostate, lung, or rectum cancer is well tolerated with minimal toxicity, improves the quality of life for patients, and has a synergistic therapeutic effect when combined”
From Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination (2021) · cites this paper as [182]
In the citing paper
“However, most of these studies were not designed as large-scale randomized clinical trials and clear verifications of the clinical efficacy of vitamin C are currently rather limited [177,182,183,184].”
From Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination (2021) · cites this paper as [182]
In the citing paper
“Vitamin C or ascorbic acid (AA) is a powerful antioxidant that can have beneficial effects on delaying the aging process and age-related diseases thorough its action on redox oxidative and mitochondrial pathways, on the immune system, on inflamm-aging, on endothelial integrity, and on lipoprotein metabolism [114,115,116,117,118,119,120,121].”
From The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence (2022) · cites this paper as [120]
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Self-citation(2014) · Medical Entomology and Zoology · Cited by 17,633
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P. G., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,895
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Chen, Q., Espey, M. G., Krishna, M. C., Mitchell, J. B., Corpe, C. P., Buettner, G. R., Shacter, E., & Levine, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506390102 · Cited by 1,075
Vitamin C pharmacokinetics: Implications for oral and intravenous use
Padayatty, S. J., Sun, H., Wang, Y., Riordan, H. D., Hewitt, S. M., Katz, A., Wesley, R. A., & Levine, M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-00010 · Cited by 992
Chen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., Khosh, D. B., Drisko, J., & Levine, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804226105 · Cited by 854
Cameron, E., & Pauling, L. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.10.3685 · Cited by 710
Chen, Q., Espey, M. G., Sun, A. Y., Lee, J.-H., Krishna, M. C., Shacter, E., Choyke, P. L., Pooput, C., Kirk, K. L., Buettner, G. R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702854104 · Cited by 676
Ma, Y., Chapman, J., Levine, M., Polireddy, K., Drisko, J., & Chen, Q. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007154 · Cited by 501
Cameron, E., & Pauling, L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4538 · Cited by 476
Expression of glucose transporters in cancers
Szablewski, L. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.004 · Cited by 453
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
Hoffer, L. J., Levine, M., Assouline, S., Melnychuk, D., Padayatty, S. J., Rosadiuk, K., Rousseau, C., Robitaille, L., & Miller, W. H. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn377 · Cited by 375
Ettinger, B. B., Pak, C. Y. C., Citron, J. T., Thomas, C., ADAMS-HUET, B. A., & Vangessel, A. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)68155-2 · Cited by 372
Vitamin C: A concentration-function approach yields pharmacology and therapeutic discoveries
Levine, M., Padayatty, S. J., & Espey, M. G. (2011) · Advances in Nutrition · doi:10.3945/an.110.000109 · Cited by 357
(2003) · PubMed · Cited by 350
Cameron, E., & Campbell, A. (1974) · Chemico-Biological Interactions · doi:10.1016/0009-2797(74)90019-2 · Cited by 344
Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters.
Agus, D. B., Gambhir, S. S., Pardridge, W. M., Spielholz, C., Baselga, J. M., Vera, J. C., & Golde, D. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119832 · Cited by 330
Welsh, J. L., Wagner, B. A., Erve, T. J. V. ‘., Zehr, P. S., Berg, D., Halfdanarson, T. R., Yee, N. S., Bodeker, K. L., Du, J., Roberts, L. J., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2070-8 · Cited by 319
Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer
Du, J., Martin, S. M., Levine, M., Wagner, B. A., Buettner, G. R., Wang, S.-H., Taghiyev, A. F., Du, C., Knudson, C. M., & Cullen, J. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1713 · Cited by 316
Bowie, A., & O'Neill, L. A. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7180 · Cited by 310
Padayatty, S. J., Sun, A. Y., Chen, Q., Espey, M. G., Drisko, J., & Levine, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011414 · Cited by 304
Vitamin C Suppresses TNFα-Induced NFκB Activation by Inhibiting IκBα Phosphorylation
Cárcamo, J. M., Pedraza, A. M., Bórquez-Ojeda, O., & Golde, D. W. (2002) · Biochemistry · doi:10.1021/bi0263210 · Cited by 280
Monti, D., Mitchell, E. P., Bazzan, A. J., Littman, S. J., Zabrecky, G. P., Yeo, C. J., Pillai, M. V., Newberg, A. B., Deshmukh, S., & Levine, M. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029794 · Cited by 274
Stephenson, C. M., Levin, R. D., Spector, T., & Lis, C. G. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2179-9 · Cited by 271
Intravenously administered vitamin C as cancer therapy: three cases
Padayatty, S. J. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050346 · Cited by 257
Sagun, K. C., Cárcamo, J. M., & Golde, D. W. (2005) · The FASEB Journal · doi:10.1096/fj.05-4107com · Cited by 243
Kurbacher, C. M., Wagner, U. A. G., Kolster, B., Andreotti, P. E., Krebs, D., & Bruckner, H. W. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04212-7 · Cited by 235
Verrax, J., & Calderón, P. B. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.016 · Cited by 235
Gagnier, J. J., Boon, H. S., Rochon, P. A., Moher, D., Barnes, J., & Bombardier, C. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.12.020 · Cited by 214
Effect of high-dose intravenous vitamin C on inflammation in cancer patients
Mikirova, N. A., Casciari, J. J., Rogers, A. S., & Taylor, P. R. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-189 · Cited by 196
Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer
Espey, M. G., Chen, P., Chalmers, B. P., Drisko, J., Sun, A. Y., Levine, M., & Chen, Q. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.007 · Cited by 192
Yeom, C. H., Jung, G. C., & Song, K. J. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.1.7 · Cited by 149
The Use of Antioxidants with First-Line Chemotherapy in Two Cases of Ovarian Cancer
Drisko, J., Chapman, J. A., & Hunter, V. J. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719284 · Cited by 147
Vollbracht, C., Schneider, B., Leendert, V., Weiß, G., Auerbach, L., & Beuth, J. (2011) · PubMed · Cited by 145
Putchala, M. C., Ramani, P., Sherlin, H. J., Premkumar, P., & Natesan, A. (2013) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2013.01.016 · Cited by 144
Corpe, C. P., Eck, P., Wang, J., Al‐Hasani, H., & Levine, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.436790 · Cited by 142
Kuiper, C., Molenaar, I. G. M., Dachs, G. U., Currie, M. J., Sykes, P. H., & Vissers, M. C. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0263 · Cited by 135
Vera, J., Rivas, C., Zhang, R., Farber, C., & Golde, D. W. (1994) · Blood · doi:10.1182/blood.v84.5.1628.1628 · Cited by 127
The orthomolecular treatment of cancer
Cameron, E., Campbell, A., & Jack, T. (1975) · Chemico-Biological Interactions · doi:10.1016/0009-2797(75)90007-1 · Cited by 124
Berenson, J. R., Matous, J., Swift, R. A., Mapes, R., Morrison, B., & Yeh, H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1812 · Cited by 124
Salani, B., Marini, C., Río, A. D., Ravera, S., Massollo, M., Orengo, A. M., Amaro, A. A., Passalacqua, M., Maffioli, S., Pfeffer, U., et al. (2013) · Scientific Reports · doi:10.1038/srep02070 · Cited by 120
Prasad, K. N., Sinha, P. K., Ramanujam, M., & Sakamoto, A. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.2.829 · Cited by 119
A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
Riordan, H. D., Casciari, J. J., González, M. J., Riordan, N. H., Miranda-Massari, J. R., Taylor, P. R., & Jackson, J. A. (2005) · PubMed · Cited by 116
Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent
Riordan, N. H., Riordan, H. D., Meng, X., Li, Y., & Jackson, J. A. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90137-x · Cited by 116
Ascorbic acid inhibits antitumor activity of bortezomib in vivo
Perrone, G., Hideshima, T., Ikeda, H., Okawa, Y., Calabrese, E., Gorgun, G., Santo, L., Cirstea, D., Raje, N., Chauhan, D., et al. (2009) · Leukemia · doi:10.1038/leu.2009.83 · Cited by 109
Non‐toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre‐treatment
Taper, H. S., de Gerlache, J., Lans, M., & Roberfroid, M. B. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400424 · Cited by 100
The orthomolecular treatment of cancer I. The role of ascorbic acid in host resistance
Cameron, E., & Pauling, L. C. (1974) · Chemico-Biological Interactions · doi:10.1016/0009-2797(74)90018-0 · Cited by 99
Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours
Casciari, J. J., Riordan, N. H., Schmidt, T. L., Meng, X., Jackson, J. A., & Riordan, H. D. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1814 · Cited by 93
Chen, P., Yu, J., Chalmers, B., Drisko, J., Yang, J., Li, B., & Chen, Q. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834fd01f · Cited by 91
Vitamin C Augments Chemotherapeutic Response of Cervical Carcinoma HeLa Cells by Stabilizing P53
Reddy, V. G., Khanna, N., & Singh, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4593 · Cited by 91
Prasad, K. N., Hernandez, C., Edwards‐Prasad, J., Nelson, J., Borus, T., & Robinson, W. A. (1994) · Nutrition and Cancer · doi:10.1080/01635589409514349 · Cited by 90
Frömberg, A., Gutsch, D., Schulze, D., Vollbracht, C., Weiß, G., Czubayko, F., & Aigner, A. M. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1418-6 · Cited by 89
Park, S., Han, S., Park, C. H., Hahm, E., Lee, S. J., Park, H. K., Lee, S., Kim, W. S., Jung, C. W., Park, K., et al. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.005 · Cited by 87
Yeom, C., Lee, G., Park, J., Yu, J., Park, S., Yi, S. Y., Lee, H. R., Hong, Y. S., Yang, J.-S., & Lee, S. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-70 · Cited by 84
Berenson, J. R., Boccia, R. V., Siegel, D. S. D., Bozdech, M. J., Bessudo, A., Stadtmauer, E. A., Pomeroy, J. T., Steis, R. G., Flam, M. S., Lutzky, J., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06280.x · Cited by 83
SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment
Hong, S.-W., Lee, S.-H., Moon, J.-H., Hwang, J. J., Kim, D. E., Ko, E., Kim, H.-S., Cho, I. J., Kang, J.-I., Kim, D. J., et al. (2012) · Oncogene · doi:10.1038/onc.2012.176 · Cited by 80
Klingelhoeffer, C., Kämmerer, U., Koospal, M., Mühling, B., Schneider, M., Kapp, M., Kübler, A. C., Germer, C., & Otto, C. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-61 · Cited by 80
Pollard, H. B., Levine, M., Eidelman, O., & Pollard, M. (2010) · PubMed · Cited by 72
Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis
Fritz, H., Kennedy, D. A., Fergusson, D. A., Fernandes, R., Doucette, S. P., Cooley, K., SEELY, A. J. E., Sagar, S. M., Wong, R. K. W., & Seely, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021107 · Cited by 71
Self-citationVitamin C uptake and recycling among normal and tumor cells from the central nervous system
Astuya, A., Caprile, T., Castro, M. A., Salazar, K., García, M. D. L. Á., Reinicke, K., Rodríguez, F., Vera, J. C., Millán, C., Ulloa, V., et al. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20326 · Cited by 71
Hong, S.-W., Jin, D.-H., Hahm, E., Yim, S.-H., Lim, J., Kim, K.-I., Yang, Y. D., Lee, S.-S., Kang, J., Lee, W.-J., et al. (2007) · Oncology Reports · doi:10.3892/or.18.4.811 · Cited by 70
High-dose intravenous vitamin C improves quality of life in cancer patients
Takahashi, H., Mizuno, H., & Yanagisawa, A. (2012) · Personalized Medicine Universe · doi:10.1016/j.pmu.2012.05.008 · Cited by 69
Oxalic acid excretion after intravenous ascorbic acid administration
Robitaille, L., Mamer, O. A., Miller, W. H., Levine, M., Assouline, S., Melnychuk, D., Rousseau, C., & Hoffer, L. J. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.023 · Cited by 67
Deubzer, B., Mayer, F. B., Kuçi, Z., Niewisch, M. R., Merkel, G., Handgretinger, R., & Bruchelt, G. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315098 · Cited by 63
Wright, M. E., Andreotti, G., Lissowska, J., Yeager, M., Zatonski, W., Chanock, S. J., Chow, W.-H., & Hou, L. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.01.027 · Cited by 62
Vuyyuri, S. B., Rinkinen, J., Worden, E., Shim, H.-K., Lee, S., & Davis, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067081 · Cited by 59
Chen, A. A., Marsit, C. J., Christensen, B. C., Houseman, E. A., McClean, M. D., Smith, J. F., Bryan, J. T., Posner, M. R., Nelson, H. H., & Kelsey, K. T. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp076 · Cited by 57
Chiang, C. D., Song, E., Yang, V., & Chao, C. C. ‐. (1994) · Biochemical Journal · doi:10.1042/bj3010759 · Cited by 55
Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.
Riordan, H. D., Riordan, N. H., Jackson, J. A., Casciari, J. J., Hunninghake, R., González, M. J., Mora, E., Miranda-Massari, J. R., Rosario, N., & Rivera, A. (2004) · PubMed · Cited by 55
Cameron, E., & Campbell, A. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90127-k · Cited by 48
Intravenous ascorbic acid: protocol for its application and use.
Riordan, H. D., Hunninghake, R., Riordan, N. H., Jackson, J. J., Meng, X., Taylor, P. B., Casciari, J. J., González, M. J., Miranda-Massari, J. R., Mora, E., et al. (2003) · PubMed · Cited by 47
Lee, S. K., Kang, J. S., Jung, D. J., Hur, D. Y., Kim, J. E., Hahm, E., Bae, S., Kim, H. W., Kim, D., Cho, B. J., et al. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21391 · Cited by 47
Selective Ascorbate Toxicity in Malignant Mesothelioma
Ranzato, E., Biffo, S., & Burlando, B. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0340oc · Cited by 46
Enhanced antitumor activity of vitamin C via p53 in Cancer cells
Kim, J., Lee, S., Chang, B., Jin, D., Jung, S., Park, M.-Y., Han, Y., Yang, Y. D., Kim, K. I., Lim, J., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.079 · Cited by 46
Vitamin C blocks TNF-α-induced NF-kB activation and ICAM-1 expression in human neuroblastoma cells
Son, E.-W., Mo, S. J., Rhee, D. K., & Pyo, S. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02975434 · Cited by 46
Ascorbic acid and cell survival of adriamycin resistant and sensitive MCF-7 breast tumor cells
Wells, W. W., Rocque, P. A., Xu, D.-P., Meyer, E. B., Charamella, L. J., & Dimitrov, N. V. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00188-p · Cited by 45
Interaction of ascorbic acid and warfarin.
Rosenthal, G. (1971) · PubMed · Cited by 42
Bannerman, B. M., Xu, L., Jones, M. D., Tsu, C. A., Yu, J., Hales, P., Monbaliu, J. G., Fleming, P. E., Dick, L. R., Manfredi, M. G., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1591-2 · Cited by 41
Abou-Jawde, R. M., Reed, J., Kelly, M., Walker, E., Andresen, S. W., Baz, R., Karam, M. A., & Hussein, M. A. (2006) · Medical Oncology · doi:10.1385/mo:23:2:263 · Cited by 41
Bhat, S. H., Azmi, A. S., Hanif, S., & Hadi, S. M. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.05.017 · Cited by 40
Park, J., Davis, K., Lee, G., Jung, M., Jung, Y., Park, J., Yi, S. Y., Lee, M. A., Lee, S., Yeom, C., et al. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.09.011 · Cited by 37
Pathak, A. K., Singh, N., Khanna, N., Reddy, V. G., Prasad, K. N., & Kochupillai, V. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719244 · Cited by 37
Erichsen, H. C., Peters, U., Eck, P., Welch, R., Schoen, R. E., Yeager, M., Levine, M., Hayes, R. B., & Chanock, S. (2008) · Nutrition and Cancer · doi:10.1080/01635580802033110 · Cited by 36
Kim, H., Kim, H., Kong, J. M., Bae, S., Kim, Y. S., Lee, N., Cho, B. J., Lee, S. K., Kim, H., Hwang, Y., et al. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22997 · Cited by 36
D’Souza, G. G. M., Wang, T., Rockwell, K. R., & Torchilin, V. P. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9674-4 · Cited by 35
Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo
Mikirova, N. A., Casciari, J. J., & Riordan, N. H. (2010) · Vascular Cell · doi:10.1186/2040-2384-2-2 · Cited by 34
An, S. H., Kang, J.-H., Kim, D.-H., & Lee, M.-S. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.3.211 · Cited by 33
Martinotti, S., Ranzato, E., & Burlando, B. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.05.023 · Cited by 33
Vitamin C Enhances Chemosensitization of Esophageal Cancer Cellsin Vitro
Abdel-Latif, M., Raouf, A. A., Sabra, K., Kelleher, D. P., & Reynolds, J. V. (2005) · Journal of Chemotherapy · doi:10.1179/joc.2005.17.5.539 · Cited by 33
Berthaut, I., Mestayer, C., Portois, M.-C., Cussenot, O., & Mowszowicz, I. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970801)32:3 · Cited by 30
Sattar, A., Willman, J. E., & Kolluri, R. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110704 · Cited by 30
Interaction of Ascorbic Acid and Warfarin
Rosenthal, G. (1971) · JAMA · doi:10.1001/jama.1971.03180230079026 · Cited by 30
Riordan, H. D., Jackson, J. A., Riordan, N. H., & Schultz, M. (1998) · Journal of orthomolecular medicine · Cited by 29
A Strategy for Controlling Potential Interactions Between Natural Health Products and Chemotherapy
Seely, D., Stempak, D., & Baruchel, S. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3180310521 · Cited by 27
Self-citationLack of a clinically important interaction between warfarin and ascorbic acid
Feetam, C., Leach, R. H., & Meynell, M. J. (1975) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(75)90278-1 · Cited by 27
Kim, J. E., Kang, J. S., & Lee, W. J. (2012) · Immune Network · doi:10.4110/in.2012.12.5.189 · Cited by 25
Sarna, S. J., & Bhola, R. (1993) · PubMed · Cited by 23
Campbell, A., Jack, T., & Cameron, E. (2009) · Oncology · doi:10.1159/000226988 · Cited by 22
Chemosensitizing effect of vitamin C in combination with 5-fluorouracil in vitro.
Nagy, B., Mucsi, I., Molnár, J., Varga, A., & Thurzó, L. (2003) · PubMed · Cited by 21
Song, E.-J., Yang, V. C., Chiang, C. D., & Chao, C. C. ‐. (1995) · European Journal of Pharmacology Environmental Toxicology and Pharmacology · doi:10.1016/0926-6917(95)90003-9 · Cited by 21
Jaipakdee, S., Prasongwatana, V., Premgamone, A., Reungjui, S., Tosukhowong, P., Tungsanga, K., Suwantrai, S., Noppawinyoowong, C., Maskasame, S., & Sriboonlue, P. (2004) · PubMed · Cited by 20
Acute Reactions to Mega Ascorbic Acid Therapy in Malignant Disease
Campbell, A., & Jack, T. (1979) · Scottish Medical Journal · doi:10.1177/003693307902400210 · Cited by 19
Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
Prasad, S. B., Giri, A., & Arjun, J. (1993) · PubMed · Cited by 12
Effects of cefodizime on non-specific immune functions in patients with multiple myeloma
Dammacco, F., & Benvestito, S. (1992) · Infection · doi:10.1007/bf01709957 · Cited by 11
Phase 1 trial of high-dose intravenous vitamin C treatment for patients with cancer.
Stephenson, C. M., Levin, R. D., & Lis, C. G. (2007) · PubMed · Cited by 4
Development of a papillary thyroid carcinoma in a patient while on high dosage ascorbic acid therapy
Campbell, A. S. (1980) · Chemico-Biological Interactions · doi:10.1016/0009-2797(80)90053-8 · Cited by 4
Marian, M., & Matkovics, B. (1982) · Cellular and Molecular Life Sciences · doi:10.1007/bf02327056 · Cited by 3
James, J., Riordan, H. D., Bramhall, N. L., & Neathery, S. S. (2002) · Journal of orthomolecular medicine · Cited by 3
Welch, J. S., Klco, J. M., Gao, F., Hassan, A., & Vij, R. (2010) · Blood · doi:10.1182/blood.v116.21.2148.2148 · Cited by 2
A NUTRITIOUS COCKTAIL FOR THE TREATMENT OF MELANOMA : A CASE REPORT
Oliveira, J. L. G. D. (1998) · Journal of orthomolecular medicine · Cited by 1
Research works printed but not linked: 26
- Vollbracht C, 2011, In Vivo, 25, 983
- Nagy B, 2003, In Vivo, 17, 289
- 10.1007/s00280-010-1418-6 · DOI
- Szablewski L, 2013, Biochim Biophys Acta, 1835, 164
- Mikirova NA, 2007, J Orthomol Med, 22, 153
- Riordan HD, 2005, P R Health Sci J, 24, 269
- Stephenson CM, 2007, J Am Osteopath Assoc, 107, 212
- Riordan HD, 1998, J Orthomol Med, 13, 72
- Riordan HD, 1990, J Orthomol Med, 5, 5
- Riordan HD, 2004, P R Health Sci J, 23, 115
- Riordan N, 1996, J Orthomol Med, 11, 80
- De Oliveira JLG, 1998, J Orthomol Med, 13, 176
- Jackson JA, 2002, J Orthomol Med, 17, 117
- Jackson JA, 1995, J Orthomol Med, 10, 87
- Hong SW, 2007, Oncol Rep, 18, 811
- Knowles HJ, 2003, Cancer Res, 63, 1764
- Pollard HB, 2010, In Vivo, 24, 249
- 10.1016/j.freeradbiomed.2011.03.007 · DOI
- Riordan HD, 2003, P R Health Sci J, 22, 287
- Jackson JA, 2006, J Orthomol Med, 21, 188
- Anderson P, Paper presented at: Conference of the Oncology Association of Naturopathic Physicians (OncANP)
- Jaipakdee S, 2004, J Med Assoc Thai, 87, 255
- Sullivan GG, Conference abstract of the Society of Integrative Oncology
- Prasad SB, 1992, Pol J Pharmacol Pharm, 44, 383
- Sarna S, 1993, Arch Immunol Ther Exp (Warsz), 41, 327
- Song EJ, 1995, Eur J Pharmacol, 292, 119
Cited by
Sorted by citations
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression
Cimmino, L., Dolgalev, I., Wang, Y., Yoshimi, A., Martin, G. H., Wang, J., Ng, V., Xia, B., Witkowski, M. T., Mitchell-Flack, M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.032 · Cited by 707
Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination
Doseděl, M., Jirkovský, E., Macáková, K., Krčmová, L., Javorská, L., Pourová, J., Mercolini, L., Remião, F., Nováková, L., Mladěnka, P., et al. (2021) · Nutrients · doi:10.3390/nu13020615 · Cited by 553
Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?
Kocot, J., Luchowska-Kocot, D., Kiełczykowska, M., Musik, I., & Kurzepa, J. (2017) · Nutrients · doi:10.3390/nu9070659 · Cited by 256
Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence
Vissers, M. C. M., & Das, A. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00809 · Cited by 188
“There is a substantial body of literature that documents potential anti-tumor effects of ascorbate in in vitro and in vivo settings, with many reporting cytotoxicity toward cancer cells and a slowing of tumor growth in animal models (for reviews, see Du et al., 2012; Park, 2013; Fritz et al., 2014; Wilson et al., 2014…”
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers
Liang, X., Weng, J., You, Z., Wang, Y., Wen, J., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02375-x · Cited by 204
Metadata
- Authors
- Fritz, H., Flower, G., Weeks, L., Cooley, K., Callachan, M., McGowan, J., Skidmore, B., Kirchner, L., & Seely, D.
- Affiliations
- Canadian College of Naturopathic Medicine (CA)
- Ottawa Integrative Cancer Centre, Ottawa, Ontario, Canada
- Carp Ridge Natural Health Clinic, Carp, Ontario, Canada
- Venue
- Integrative Cancer Therapies
- Publisher
- SAGE Publications
- Published
- 2014-05-26
- Volume
- 13
- Issue
- 4
- Pages
- 280-300
- ISSN
- 1534-7354 (ISSN-L)
- 1552-695X
- OpenAlex
- W2100763849
- Cited by
- 124
- References
- 111
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 15 · 2021: 15 · 2020: 12 · 2019: 15 · 2018: 13 · 2017: 8 · 2016: 8 · 2015: 9 · 2014: 1
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Integrative Cancer Therapies (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- intravenous vitamin C, vitamin C, cancer therapy, adjunctive therapy, integrative oncology, naturopathy, chemotherapy toxicity, tumor regression, quality of life, safety profile, anticancer activity
- MeSH terms
- Antineoplastic Combined Chemotherapy Protocols, Ascorbic Acid, Humans, Infusions, Intravenous, Neoplasms, Quality of Life, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
